❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ News archive ❭

Institute seminar September 10th 12:00 Ingrid Roxrud

I. Roxrud
I. Roxrud

The institute seminar on Wednesday September 10th will be held by Ingrid Roxrud from The Department of Biochemistry.

The title of her talk is "Turning off growth factor signaling: endocytosis and the road to degradation"

Time and place: 12:00, Seminar Room, F4, Institute for Cancer Research.


Links:

Ingrid Roxrud

Harald Stenmark's group

Department of Biochemistry

Institute seminars autumn 2008

 
Scroll to top

Home Cancer Medicine Institute for Cancer Research

  • Dept. of Cancer Genetics
  • Dept. of Cancer Immunology
  • Dept. of Molecular Cell Biology
  • Dept. of Molecular Oncology
  • Dept. of Radiation Biology
  • Dept. of Tumor Biology
  • Dept. of Core Facilities
  • Institute employees
  • Dept./group overview
  • Publications
  • Institute administration
  • Annual reports
  • Institute seminars
  • Vacant positions
  • News archive
  • Scientific Advisory Board
  • ehåndbok/HES procedures

Recent publications

From major journals, first or last author from the Institute for Cancer Research

Landsverk HB, Sandquist LE, Bay LTE, Hauge S, van Bijsterveldt L, Lindbergsengen L, Lund-Andersen C, Kanduri C, Lyng H, Fjeldbo CS, Hompland T, Humphrey TC, Syljuåsen RG (2026)
Transcription termination counteracts DNA damage after WEE1 inhibition
Nucleic Acids Res, 54 (3)
DOI 10.1093/nar/gkaf1487, PubMed 41569153

Solli E, Bevilacqua A, Wenes M, Migliorini D, van der Veen L, Skånland SS, Di Conza G, Taskén K (2026)
The PI3Kδ inhibitor roginolisib (IOA-244) preserves T-cell function and activity
Mol Oncol (in press)
DOI 10.1002/1878-0261.70203, PubMed 41568714

Teles-Reis J, Rusten TE (2026)
Tumour-host interactions in Drosophila: mechanisms in the tumour micro- and macroenvironment
Mol Oncol (in press)
DOI 10.1002/1878-0261.70207, PubMed 41546533

More selected publications

Most recent publications

Solli E, Bevilacqua A, Wenes M, Migliorini D, van der Veen L, Skånland SS, Di Conza G, Taskén K (2026)
The PI3Kδ inhibitor roginolisib (IOA-244) preserves T-cell function and activity
Mol Oncol (in press)
DOI 10.1002/1878-0261.70203, PubMed 41568714

Landsverk HB, Sandquist LE, Bay LTE, Hauge S, van Bijsterveldt L, Lindbergsengen L, Lund-Andersen C, Kanduri C, Lyng H, Fjeldbo CS, Hompland T, Humphrey TC, Syljuåsen RG (2026)
Transcription termination counteracts DNA damage after WEE1 inhibition
Nucleic Acids Res, 54 (3)
DOI 10.1093/nar/gkaf1487, PubMed 41569153

Teles-Reis J, Rusten TE (2026)
Tumour-host interactions in Drosophila: mechanisms in the tumour micro- and macroenvironment
Mol Oncol (in press)
DOI 10.1002/1878-0261.70207, PubMed 41546533

More publications

Annual summary of publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)